Neurontin for Charles Bonnet Syndrome.
Finucane
Thomas E
TE
D000588:Amines / Q000627:therapeutic use*; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D000077206:Gabapentin; D006212:Hallucinations / Q000188:drug therapy*; D006801:Humans; D008389:Marketing of Health Services / Q000331:legislation & jurisprudence*; D013577:Syndrome; D014481:United States; D015354:Vision, Low; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
D000588:Amines; D002491:Central Nervous System Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin